Evaluating the Efficacy of the eNav Toolkit to Improve Colorectal Cancer Screening
Launched by ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · Dec 14, 2023
Trial Information
Current as of July 25, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This is a multi-site randomized clinical trial to evaluate the efficacy of the eNav Toolkit. A total of 400 participants will be from four FQHC clinics within the Institute for Family Health FQHC network. Participants will be randomly assigned to one of two groups:
1. eNav group (N=200) or
2. usual care group (N=200)
Participants will consent and complete a baseline questionnaire (demographics, medical information) 1-4 weeks before their primary care appointment.
Those in the intervention group will receive a link to the eNav website. The digital navigation tool includes a website and te...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient treated at the Institute for Family Health (IFH)
- • Patient 45 to 75 years old
- • English or Spanish speaking
- • Able to provide consent within the study time frame (within a month of the primary care appointment
- • Patients have access to a computer, tablet or mobile device to access the eNav Toolkit OR willing to use a clinic provided device, in person at either IFH OR Mount Sinai
- • Patient scheduled for a primary care appointment at IFH
- • Patients are due for colorectal cancer screening (as determined by the health maintenance alert in the medical chart)
- Exclusion Criteria:
- • Unable to provide informed consent
About Icahn School Of Medicine At Mount Sinai
The Icahn School of Medicine at Mount Sinai is a premier academic institution located in New York City, renowned for its commitment to advancing medical research, education, and patient care. As a leading sponsor of clinical trials, the institution leverages its state-of-the-art facilities and multidisciplinary expertise to drive innovative research initiatives aimed at improving health outcomes. With a focus on translational medicine, the Icahn School of Medicine collaborates with a diverse network of researchers, clinicians, and industry partners to explore novel therapies and interventions across a wide range of medical disciplines. Its rigorous scientific approach and dedication to ethical standards position it as a trusted leader in the clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Sarah Miller, PsyD
Principal Investigator
Icahn School of Medicine at Mount Sinai
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported